United States · Platforms & data · TipRanks

Neurosterix Closes $105 Million Series B Financing

Published by TipRanks · United States 10 h ago

Detailed summary

Addex Therapeutics ( ($CH:ADXN) ) has issued an announcement. Addex Therapeutics, a clinical-stage biopharmaceutical company developing small-molecule allosteric ...

Read the full article on TipRanks Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tipranks.com)

Also worth reading

MarketBeat

Automatic Data Processing, Inc. (NASDAQ:ADP) Plans Quarterly Dividend of $1.90

The Motley Fool

Dell Technologies vs. Taiwan Semiconductor: Which Technology Stock Is a Better Buy for 2027?

MarketWatch

Neurosterix Closes $105 Million Series B Financing

Detailed summary

Share

Also worth reading

Automatic Data Processing, Inc. (NASDAQ:ADP) Plans Quarterly Dividend of $1.90

Dell Technologies vs. Taiwan Semiconductor: Which Technology Stock Is a Better Buy for 2027?

Your holiday credit-card bills are going up. What you can do to ease the pain.

Here are the major earnings before the open Thursday

AEVEX Q3 2026 slides: core business surges as Ukraine revenue fades

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire